By Andrew Silver SHANGHAI, Jan 30 (Reuters) - AstraZeneca will license experimental drugs for obesity and weight-related ...
By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...
AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...
British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its ...
AstraZeneca to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines: Cambridge, UK Friday, January 30, 2026, 09:00 Hrs [IST] AstraZeneca ...
UK-Swedish drugmaker AstraZeneca plans to invest USD15 billion in China over the next five years to expand its drug ...
CSPC Pharmaceutical Group Ltd (HK:1093) announced a major strategic partnership with AstraZeneca PLC (ST:AZN), marking one of ...
Pharmaceutical Technology on MSN
AstraZeneca pours $15bn into Chinese R&D and manufacturing operations
This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative ...
AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full ...
Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the ...
AstraZeneca announces a $15B China investment through 2030 to expand manufacturing and R&D in cell therapy and ...
Jan 30 (Reuters) - CSPC Pharmaceutical Group said on Friday it had entered an agreement with UK drugmaker AstraZeneca for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results